Home › Funds › Frazier Life Sciences Management, L.P. › SVRA

Frazier Life Sciences Management, L.P. position in SVRA

Savara Inc · Health Care

Frazier Life Sciences Management, L.P. reported holding 9,720,852 shares of SVRA (Savara Inc) in its Q2 2026 13F filing — a position valued at US$59.9M, representing 1.30% of its reported portfolio and ranking #16 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed SVRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)9.72M sh
Reported value held$59.88M
Portfolio Weight1.30%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s SVRA position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in SVRA in Q3 2023 at 4,000,000 shares (US$15.1M). The position peaked in Q2 2026 at 9,720,852 shares, worth US$59.9M. Across 12 filings, Frazier Life Sciences Management, L.P. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 9,720,852 shares valued at US$59.9M. Notable position changes include a 104% increase in Q2 2024 (shares rose 5% over the following quarter), a 32% increase in Q1 2025 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.00M $15.12M New
Q4 2023 4.00M $18.80M Hold
Q1 2024 4.00M $19.92M Hold
Q2 2024 8.16M $32.87M Add
Q3 2024 8.16M $34.59M Hold
Q4 2024 8.66M $26.59M Add
Q1 2025 11.46M $31.75M Add
Q2 2025 11.46M $26.13M Hold
Q3 2025 11.46M $40.92M Hold
Q4 2025 9.86M $59.47M Reduce
Q1 2026 9.72M $53.08M Reduce
Q2 2026 9.72M $59.88M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SVRA and 13F data

SVRA (Savara Inc) is a Health Care company. 44 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), Venrock Adviser, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SVRA

All SVRA fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held SVRA?

Frazier Life Sciences Management, L.P. has disclosed SVRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Frazier Life Sciences Management, L.P.'s current position in SVRA?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 9.72M shares of SVRA (Savara Inc), valued at $59.88M, representing 1.30% of its reported portfolio and ranking #16.

Has Frazier Life Sciences Management, L.P. been buying or selling SVRA?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in SVRA. The position peaked in Q2 2026 at 9.72M shares.

Which other funds hold SVRA?

Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, Venrock Adviser, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.